Showing results (51-60 of 175) with videos related to

Sort By:
Pageof 18
Haematologica|February 22, 2020
Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphomaMatias Autio, Suvi-Katri Leivonen, Oscar Brück, et al.
Molecular Cancer Therapeutics|March 13, 2015
The tyrosine kinase inhibitors imatinib and dasatinib reduce myeloid suppressor cells and release effector lymphocyte responsesLisa Christiansson, Stina Söderlund, Sara Mangsbo, et al.
Cancers|March 20, 2020
<i>STAT3</i> Mutation Is Associated with STAT3 Activation in CD30<sup>+</sup> ALK<sup>-</sup> ALCLEmma I Andersson, Oscar Brück, Till Braun, et al.
Elife|November 6, 2024
Single-cell multiomics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy responseRebecca Warfvinge, Linda Geironson Ulfsson, Parashar Dhapola, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 3, 2021
Spatial immunoprofiling of the intratumoral and peritumoral tissue of renal cell carcinoma patientsOscar Brück, Moon Hee Lee, Riku Turkki, et al.
Hemasphere|March 2, 2022
Targeting Apoptosis Pathways With BCL2 and MDM2 Inhibitors in Adult B-cell Acute Lymphoblastic LeukemiaHelena Hohtari, Matti Kankainen, Shady Adnan-Awad, et al.
Scientific Reports|March 14, 2019
Characterization of polydactyly chondrocytes and their use in cartilage engineeringEmma Cavalli, Clara Levinson, Matthias Hertl, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2018
Sex bias in MHC I-associated shaping of the adaptive immune systemTilman Schneider-Hohendorf, Dennis Görlich, Paula Savola, et al.
Human Molecular Genetics|December 13, 2018
A robust pipeline with high replication rate for detection of somatic variants in the adaptive immune system as a source of common genetic variation in autoimmune diseaseLies Van Horebeek, Kelly Hilven, Klara Mallants, et al.
Haematologica|December 30, 2017
CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targetingNiklas Landberg, Sofia von Palffy, Maria Askmyr, et al.
Pageof 18